{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:59:14Z","timestamp":1785499154182,"version":"3.56.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ejim.2026.107111","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:23:36Z","timestamp":1785497016000},"page":"107111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Biological therapy in Takayasu arteritis. Results from the REVAS registry"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6612-221X","authenticated-orcid":false,"given":"J","family":"Mestre-Torres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JL","family":"Callejas-Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9203-7008","authenticated-orcid":false,"given":"M","family":"P\u00e9rez-Conesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9648-1456","authenticated-orcid":false,"given":"B","family":"de Escalante-Yang\u00fcela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"N\u00fa\u00f1ez-Conde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2673-2034","authenticated-orcid":false,"given":"F","family":"Mart\u00ednez-Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0578-7474","authenticated-orcid":false,"given":"EM","family":"Fonseca-Aizpuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0058-1293","authenticated-orcid":false,"given":"R","family":"Solans-Laqu\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"65","key":"10.1016\/j.ejim.2026.107111_bib0001","first-page":"1","article-title":"Revised International Chapel Hill Consensus Conference nomenclature of vasculitides","volume":"2013","author":"Jennette","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.ejim.2026.107111_bib0002","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/BOR.0000000000000983","article-title":"Epidemiology of systemic vasculitis","volume":"36","author":"Ozguler","year":"2024","journal-title":"Curr Opin Rheumatol"},{"issue":"11","key":"10.1016\/j.ejim.2026.107111_bib0003","doi-asserted-by":"crossref","first-page":"4982","DOI":"10.1093\/rheumatology\/keab406","article-title":"A systematic review and meta-analysis of the incidence rate of Takayasu arteritis","volume":"60","author":"Rutter","year":"2021","journal-title":"Rheumatol (U K)"},{"key":"10.1016\/j.ejim.2026.107111_bib0004","first-page":"1","article-title":"EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update","author":"Dejaco","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ejim.2026.107111_bib0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/annrheumdis-2019-215672","article-title":"2018 Update of the EULAR recommendations for the management of large vessel vasculitis","volume":"79","author":"Hellmich","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.ejim.2026.107111_bib0006","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/art.41774","article-title":"2021 American college of rheumatology\/vasculitis foundation guideline for the management of giant cell arteritis and Takayasu Arteritis","volume":"73","author":"Maz","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.ejim.2026.107111_bib0007","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/annrheumdis-2019-215672","article-title":"2018 Update of the EULAR recommendations for the management of large vessel vasculitis","volume":"79","author":"Hellmich","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.ejim.2026.107111_bib0008","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/acr.24632","article-title":"2021 American college of rheumatology\/vasculitis foundation guideline for the management of giant cell arteritis and Takayasu Arteritis","volume":"73","author":"Maz","year":"2021","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.ejim.2026.107111_bib0009","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/rheumatology\/kead387","article-title":"Treatment efficacy and safety of Adalimumab versus Tocilizumab combined with methotrexate and glucocorticoids in patients with active and severe Takayasu arteritis: a randomized, open-label, head-to-head study","volume":"63","author":"Wang","year":"2024","journal-title":"Rheumatol"},{"key":"10.1016\/j.ejim.2026.107111_bib0010","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1093\/rheumatology\/keab635","article-title":"Efficacy and safety of TNF-\u03b1 antagonists and tocilizumab in Takayasu arteritis: multicentre retrospective study of 209 patients","volume":"61","author":"Mekinian","year":"2022","journal-title":"Rheumatol (U K)"},{"key":"10.1016\/j.ejim.2026.107111_bib0011","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/art.42496","article-title":"Comparative efficacy of Secukinumab versus tumor necrosis factor inhibitors for the treatment of Takayasu arteritis","volume":"75","author":"Tian","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ejim.2026.107111_bib0012","doi-asserted-by":"crossref","first-page":"919","DOI":"10.7326\/0003-4819-120-11-199406010-00004","article-title":"Takayasu arteritis","volume":"120","author":"Kerr","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2026.107111_bib0013","first-page":"S86","article-title":"Review assessment of disease activity and progression in Takayasu \u2019 s arteritis","volume":"29","author":"Direskeneli","year":"2011","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"10.1016\/j.ejim.2026.107111_bib0014","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/acr.25275","article-title":"Development of the Takayasu Arteritis integrated disease activity index","volume":"76","author":"Marvisi","year":"2024","journal-title":"Arthritis Care Res (Hob)"},{"issue":"8","key":"10.1016\/j.ejim.2026.107111_bib0015","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/art.1780330811","article-title":"The American college of rheumatology 1990 criteria for the classification of Takayasu arteritis","volume":"33","author":"Arend","year":"1990","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ejim.2026.107111_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2024.152446","article-title":"Comparison of methotrexate and azathioprine as the first-line steroid-sparing immunosuppressive agents in patients with Takayasu\u2019s arteritis","volume":"66","author":"Kaymaz-Tahra","year":"2024","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.ejim.2026.107111_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1759720X20930114","article-title":"Efficacy and safety of leflunomide versus cyclophosphamide for initial-onset Takayasu arteritis: a prospective cohort study","volume":"12","author":"Ying","year":"2020","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.ejim.2026.107111_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-017-1316-y","article-title":"TNF inhibitors appear to inhibit disease progression and improve outcome in Takayasu arteritis; an observational, population-based time trend study","volume":"19","author":"Gudbrandsson","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.ejim.2026.107111_bib0019","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002830","article-title":"Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study","volume":"9","author":"Mekinian","year":"2023","journal-title":"RMD Open"},{"issue":"2","key":"10.1016\/j.ejim.2026.107111_bib0020","doi-asserted-by":"crossref","first-page":"129","DOI":"10.55563\/clinexprheumatol\/1xi8ag","article-title":"Failure of first anti-TNF agent in Takayasu\u2019s arteritis: to switch or to swap?","volume":"39","author":"Campochiaro","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ejim.2026.107111_bib0021","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/1756-185X.13137","article-title":"Sarcoidosis with Takayasu arteritis : a model of overlapping granulomatosis. A report of seven cases and literature review","volume":"21","author":"Chapelon-abric","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.ejim.2026.107111_bib0022","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s12026-024-09476-7","article-title":"Exploring the causal relationship between Takayasu arteritis and inflammatory bowel disease using mendelian randomization","volume":"72","author":"Pang","year":"2024","journal-title":"Immunol Res [Internet]"},{"issue":"November 2017","key":"10.1016\/j.ejim.2026.107111_bib0023","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejim.2017.11.003","article-title":"Biological treatments in giant cell arteritis & Takayasu arteritis","volume":"50","author":"Samson","year":"2018","journal-title":"Eur J Intern Med [Internet]"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620526004164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620526004164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:23:39Z","timestamp":1785497019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620526004164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":23,"alternative-id":["S0953620526004164"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2026.107111","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biological therapy in Takayasu arteritis. Results from the REVAS registry","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2026.107111","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Federation of Internal Medicine. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107111"}}